| Alisha Ann Sandidge, FNP-C | |
|
400 W Mineral King Ave, Visalia, CA 93291-6237 | |
| (559) 624-5425 | |
| (559) 624-5425 |
| Full Name | Alisha Ann Sandidge |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 400 W Mineral King Ave, Visalia, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063933422 | NPI | - | NPPES |
| 95006600 | Other | CA | CALIFORNIA BRN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 95006600 (California) | Primary |
| Entity Name | Kaweah Delta Health Care Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619353042 PECOS PAC ID: 4082923818 Enrollment ID: O20151019001526 |
News Archive
Researchers have discovered a way to better predict progression of Alzheimer's disease. By imaging microglial activation levels with positron emission tomography, researchers were able to better predict progression of the disease than with beta-amyloid PET imaging, according to a study published in the April issue of the Journal of Nuclear Medicine.
A brain study in infant rats demonstrates that the anti-epilepsy drug phenobarbital stunts neuronal growth, which could prompt new questions about using the first-line drug to treat epilepsy in human newborns.
Patients with chronic kidney disease, and dialysis patients especially, have a significantly higher cardiovascular morbidity and mortality than healthy people. Kidney transplantation is the best renal replacement therapy available.
JHL Biotech, Inc., an emerging biopharmaceutical company, today announced that it has closed a Series C fundraising of $45.6 million, led by funds managed by a global renowned crossover fund with over US$1.6 trillion in AUM, with participation from existing investor Milestone Capital and new investors Sungent BioVenture and Liwick Investment Management.
Bioheart, Inc. announced that treatment with stem cell therapy on two congestive heart failure (CHF) patients was performed successfully at the Hospital Angeles Tijuana, Mexico, through Bioheart's Center of Excellence program with Regenerative Medicine Institute.
› Verified 6 days ago
| Entity Name | Riverway Medical Group A Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265046395 PECOS PAC ID: 6204248701 Enrollment ID: O20201207001302 |
News Archive
Researchers have discovered a way to better predict progression of Alzheimer's disease. By imaging microglial activation levels with positron emission tomography, researchers were able to better predict progression of the disease than with beta-amyloid PET imaging, according to a study published in the April issue of the Journal of Nuclear Medicine.
A brain study in infant rats demonstrates that the anti-epilepsy drug phenobarbital stunts neuronal growth, which could prompt new questions about using the first-line drug to treat epilepsy in human newborns.
Patients with chronic kidney disease, and dialysis patients especially, have a significantly higher cardiovascular morbidity and mortality than healthy people. Kidney transplantation is the best renal replacement therapy available.
JHL Biotech, Inc., an emerging biopharmaceutical company, today announced that it has closed a Series C fundraising of $45.6 million, led by funds managed by a global renowned crossover fund with over US$1.6 trillion in AUM, with participation from existing investor Milestone Capital and new investors Sungent BioVenture and Liwick Investment Management.
Bioheart, Inc. announced that treatment with stem cell therapy on two congestive heart failure (CHF) patients was performed successfully at the Hospital Angeles Tijuana, Mexico, through Bioheart's Center of Excellence program with Regenerative Medicine Institute.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alisha Ann Sandidge, FNP-C 3611 N Silvervale Ct, Visalia, CA 93291-6553 Ph: (559) 799-6012 | Alisha Ann Sandidge, FNP-C 400 W Mineral King Ave, Visalia, CA 93291-6237 Ph: (559) 624-5425 |
News Archive
Researchers have discovered a way to better predict progression of Alzheimer's disease. By imaging microglial activation levels with positron emission tomography, researchers were able to better predict progression of the disease than with beta-amyloid PET imaging, according to a study published in the April issue of the Journal of Nuclear Medicine.
A brain study in infant rats demonstrates that the anti-epilepsy drug phenobarbital stunts neuronal growth, which could prompt new questions about using the first-line drug to treat epilepsy in human newborns.
Patients with chronic kidney disease, and dialysis patients especially, have a significantly higher cardiovascular morbidity and mortality than healthy people. Kidney transplantation is the best renal replacement therapy available.
JHL Biotech, Inc., an emerging biopharmaceutical company, today announced that it has closed a Series C fundraising of $45.6 million, led by funds managed by a global renowned crossover fund with over US$1.6 trillion in AUM, with participation from existing investor Milestone Capital and new investors Sungent BioVenture and Liwick Investment Management.
Bioheart, Inc. announced that treatment with stem cell therapy on two congestive heart failure (CHF) patients was performed successfully at the Hospital Angeles Tijuana, Mexico, through Bioheart's Center of Excellence program with Regenerative Medicine Institute.
› Verified 6 days ago
George J Moussally, MSN,ACNP-BC,CCRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 400 W Mineral King Ave, Visalia, CA 93291 Phone: 559-624-2000 | |
Kimberly Echevarria, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3130 W Caldwell Ave, Visalia, CA 93277 Phone: 559-635-7800 | |
Joanne Galindo, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 221 E Caldwell Ave, Visalia, CA 93277 Phone: 559-732-4726 | |
San Juanita Barbosa Castellano, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 5400 W. Hillsdale Drive, Visalia, CA 93291 Phone: 559-738-7500 Fax: 559-627-0106 | |
Melissa D. Gerardo, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2300 W Sunnyside Ave, Visalia, CA 93277 Phone: 888-744-2637 | |
Mrs. Julieann Gonzales, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 5400 W Hillsdale Ave, Visalia, CA 93291 Phone: 559-738-7500 | |
Jessica Nicole Jaimez, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1633 S Court St, Visalia, CA 93277 Phone: 559-624-2000 |